http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2334241-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4180fc57a693864e2ce2dbfd64a9278 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate | 2005-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05198d41bb132e704d7bf73097bc437a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_724d0f8f47fadb6ba8ccdb883aad55b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08fa9936373f15644525c05a2fb2a361 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bf14e62ece7e142d8ad1646b7e007eb |
| publicationDate | 2010-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2334241-T3 |
| titleOfInvention | COMPOUNDS TO TREAT SCHISOPHRENIA AND / OR ANOMALIES IN THE GLUCOSE REGULATION. |
| abstract | A compound of formula I ** (See formula) ** where m is 0, 1 or 2; n is 0, 1 or 2; p is 0 or 1; each R is independently hydrogen, halogen, trifluoromethyl, C1-C6 alkyl, C1-C6 alkoxy, benzyloxy, hydroxy, nitro or amino; each R1 is independently hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C1-C6 alkanoyl, halogen, cyano, -C (O) C1-C6 alkyl, -C1-C6 alkylene, CN-C1-C6 alkylene ) NR''R '' '' where R '' and R '' '' are each independently hydrogen or C1-C6 alkyl, (C1-C6) alkylene (OC) C1-C6 alkyl, or -CH ( OH) R4 where R4 is hydrogen or C1-C6 alkyl; R2 is hydrogen, C1-C6 alkyl optionally substituted by halogen, hydroxy or benzyloxy, C2-C6 alkenyl, C2-C6 alkynyl, -CO2 C1-C6 alkyl, or -R5-NR '' R '' '' where R5 is C1 alkylene -C6, C2-C6 alkenylene or C2-C6 alkynylene and R '' and R '' '' are each independently hydrogen, C1-C6 alkyl or alternatively the group -NR''R '' '' together is 1- pyrrolidinyl; and R3 is hydrogen, nitro, amino, halogen, C1-C6 alkoxy, hydroxy or C1-C6 alkyl. or one of its pharmaceutically acceptable salts, for use in the treatment of schizophrenia in a human being. |
| priorityDate | 2004-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 316.